The difference between “I want to start a pharma brand” and “I’m launching a pharma brand” is almost always one thing: a clear product brief and a manufacturer relationship. Everything else — the brand name, the logo, the marketing materials — is downstream of knowing which products you’re launching and who will make them.
This guide is for entrepreneurs and business owners who want to launch their own medicine brand through India’s private label pharma manufacturing system. It covers the steps, the timelines, the documents, and the common mistakes — written for someone who knows they want to do this but needs a clear map of how it actually works.
For the broader third-party manufacturing model: Complete Guide to Third-Party Pharma Manufacturing in India · PCD vs Third-Party Manufacturing — Which Model?
What Private Label Pharma Manufacturing Actually Means
Private label pharma manufacturing (known in the industry as third-party manufacturing or loan license manufacturing) works like this:
- You identify the products you want to sell
- You find a licensed, GMP-compliant pharmaceutical manufacturer (CMO)
- You get a loan license from your state Drug Controller, naming the CMO as your manufacturing facility
- The CMO manufactures the products under your brand name, to your label specification
- You distribute and market the products as your brand
What you own: Your brand, your customer relationships, your distribution network, your physician relationships.
What you don’t need: A manufacturing plant, a production team, a QA lab. The CMO provides all of this.
What you remain responsible for: The drug license (regulatory compliance), product quality assurance (the qualified person requirement), and the commercial obligations of the brand.
Step 1: Product Selection — The Decision That Matters Most
The most common mistake in a first pharma brand launch is spending more time on the brand name and logo than on product selection. Your brand can have a great name and beautiful artwork — if the products don’t have physician prescribing demand, the brand won’t grow.
The product selection criteria:
| Criterion | Question to Ask |
|---|---|
| Physician demand | Is this product currently being prescribed by the physician type you plan to target? |
| Prescribing frequency | How often does this physician type write this product? Monthly? Weekly? Once a year? |
| Competition | How many established brands already serve this market? Is there room for a new brand? |
| Repeat prescription potential | Is this a chronic condition (monthly repeats) or acute only? |
| Manufacturing feasibility | Can your CMO produce this product at your target MOQ and quality? |
| Price ceiling | If the product is scheduled under DPCO, does the margin structure work at the ceiling price? |
A product that scores well across all six criteria is your anchor product. Build the first 3–5 products around categories that serve the same physician, so a single representative call can present multiple products.
Step 2: The Drug License — Regulatory Foundation
Before any manufacturing begins, you need a drug license. For a new pharma marketing company operating under a loan license arrangement:
DRUG LICENSE (LOAN LICENSE) APPLICATION CHECKLIST
Regulatory category: Form 20B (loan license for manufacture elsewhere)
Required documents:
□ Completed application form (Form 21C or equivalent per state)
□ Proof of premises (rental agreement or ownership for your office/warehouse)
□ Premises layout plan (showing storage, office, quality management areas)
□ Qualified person appointment letter + B.Pharma/M.Pharma certificate + registration
□ Copy of loan licensor's (manufacturer's) drug manufacturing license
□ List of products to be manufactured (with composition)
□ Manufacturing agreement with the loan licensor
□ Company registration documents (GST, incorporation if company)
□ Applicant ID and address proof
□ Application fee payment receipt
Processing time: Varies by state — typically 45–90 working days
After receipt: Drug Controller inspection of your premises before grant
Each state Drug Controller has specific requirements — consult a regulatory consultant for your state’s exact application process.
Step 3: The Manufacturing Agreement — The Commercial Contract
Before manufacturing begins, you need a formal agreement with your CMO that specifies:
- The products to be manufactured (composition, pack size, specification)
- The brand owner’s (your) name and address for the label
- Quality responsibilities (COA, stability data obligations)
- Pricing and payment terms
- MOQ commitments and repeat order terms
- Intellectual property — that you own the brand name and label design
- Termination and notice provisions
This agreement also supports your drug license application — the state Drug Controller typically requires a copy as part of the loan license filing.
Step 4: Artwork — Start With the Requirement Sheet
The most avoidable cause of launch delays is starting artwork with a designer’s creative brief rather than the manufacturer’s label requirement sheet.
Ask your manufacturer for their label requirement document for your chosen pack size before briefing your designer. This document specifies every mandatory label element, minimum font sizes, batch coding area dimensions, and scheduling mark requirements. A designer who works from this document as their starting brief produces compliant artwork in one revision round. A designer who starts from aesthetics typically needs three.
Full details: Pharma Product Artwork & Packaging Approval Guide
Step 5: The First Batch — From Contract to Dispatch
FIRST BATCH TIMELINE (REALISTIC WORKING-DAY ESTIMATE)
Week 1-2: Manufacturing agreement signed; API sourcing confirmed
Week 3-4: Artwork brief to designer; label requirement sheet provided
Week 4-5: Artwork first draft — manufacturer compliance check
Week 5-6: Artwork revisions + final manufacturer approval
Week 6-8: Packaging component procurement (bottles, cartons, labels)
Week 8-12: Manufacturing — mixing, filling, QC testing, batch release
Week 12-14: Dispatch preparation; documentation; delivery
REALISTIC FIRST BATCH TIMELINE: 90–110 working days from contract signing
(For a new product with standard composition; add 4-6 weeks for formulation development)
The most common extension: artwork revision cycles (add 2–4 weeks) and drug license grant delays (which you can work around by having the DL application in process before manufacturing commences, if your regulatory consultant confirms the state permits this).
Mistakes to Avoid in Your First Launch
| Mistake | Why It Happens | How to Avoid |
|---|---|---|
| Choosing products before choosing your physician target | Excitement about a product without checking if the right physician is accessible | Identify your physician target first; then choose products they prescribe |
| Starting design before getting the label requirement sheet | Treating artwork as a creative task | Ask manufacturer for requirement sheet on Day 1 |
| Ordering too many SKUs in the first batch | Fear of not having enough variety | 3–5 SKUs maximum; depth before width |
| Underestimating working capital for second batch | Assuming first-batch revenue funds next batch | Plan working capital for 2 batch cycles before launch |
| Not visiting the manufacturer before the first order | Trusting phone calls and emails | Visit the facility. Non-negotiable. |
Conclusion
Launching a pharma brand through private label manufacturing in India is commercially viable at smaller scale than most entrepreneurs realise — the loan license system, the availability of GMP-compliant CMOs like Saar Biotech, and the established third-party manufacturing ecosystem remove the capital barriers of owned manufacturing.
What it requires is a clear product brief, a compliant manufacturing partner, a drug license, and the discipline to focus on physician relationships before everything else.
Ready to take the first step?